• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典自身免疫性和丙型肝炎相关慢性肝病中LKM-1抗体反应性的缺失。瑞典内科肝脏俱乐部。

Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club.

作者信息

Lindgren S, Braun H B, Michel G, Nemeth A, Nilsson S, Thome-Kromer B, Eriksson S

机构信息

Dept. of Medicine, University of Lund, Malmö General Hospital, Sweden.

出版信息

Scand J Gastroenterol. 1997 Feb;32(2):175-8. doi: 10.3109/00365529709000189.

DOI:10.3109/00365529709000189
PMID:9051879
Abstract

BACKGROUND

Type-2 autoimmune hepatitis is a subgroup of chronic hepatitis characterized by the presence of liver/kidney microsomal autoantibodies type 1 (LKM-1). A frequent association with chronic hepatitis C suggests that hepatitis virus might trigger autoimmune reactivity. LKM-1-positive chronic hepatitis is not uncommon in southern Europe but is rarely seen in the USA and the UK. The prevalence in Scandinavia is hitherto unknown.

METHODS

We used an automated prototype LKM-1 immunometry-based assay (IMx) to detect LKM-1 antibodies in sera from 350 Swedish patients with chronic liver diseases (100 with primary biliary cirrhosis, 80 with primary sclerosing cholangitis, 100 with hepatitis C, and 70 patients with various forms of chronic hepatitis, including 36 autoimmune cases), and from 17 children with autoimmune hepatitis. Sera reactive in the IMx assay were subjected to immunofluorescence testing.

RESULTS

No clearly LKM-reactive sera were detected. Serum samples from 29 patients were borderline reactive in the IMx assay but tested negative in the confirmatory immunofluorescence test. Positive tests in the former assay were likely caused by reactivity against microsomal antigens other than LKM-1/cytochrome P450IID6.

CONCLUSIONS

LKM-1-positive type-2 autoimmune hepatitis is very rare in Sweden. Furthermore, chronic hepatitis C did not trigger this type of autoimmune reactivity in our patients, probably owing to genetic insusceptibility.

摘要

背景

2型自身免疫性肝炎是慢性肝炎的一个亚组,其特征为存在1型肝/肾微粒体自身抗体(LKM-1)。与慢性丙型肝炎的频繁关联提示肝炎病毒可能引发自身免疫反应。LKM-1阳性慢性肝炎在南欧并不少见,但在美国和英国很少见。斯堪的纳维亚半岛的患病率迄今未知。

方法

我们使用基于LKM-1免疫比浊法的自动化原型检测方法(IMx),检测350例瑞典慢性肝病患者(100例原发性胆汁性肝硬化患者、80例原发性硬化性胆管炎患者、100例丙型肝炎患者以及70例各种形式慢性肝炎患者,包括36例自身免疫性病例)和17例自身免疫性肝炎儿童的血清中的LKM-1抗体。对IMx检测中有反应性的血清进行免疫荧光检测。

结果

未检测到明显的LKM反应性血清。29例患者的血清样本在IMx检测中呈临界反应性,但在确证性免疫荧光检测中呈阴性。前一种检测中的阳性结果可能是由于对LKM-1/细胞色素P450IID6以外的微粒体抗原产生反应所致。

结论

LKM-1阳性2型自身免疫性肝炎在瑞典非常罕见。此外,在我们的患者中,慢性丙型肝炎并未引发这种自身免疫反应,可能是由于基因不敏感性。

相似文献

1
Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club.瑞典自身免疫性和丙型肝炎相关慢性肝病中LKM-1抗体反应性的缺失。瑞典内科肝脏俱乐部。
Scand J Gastroenterol. 1997 Feb;32(2):175-8. doi: 10.3109/00365529709000189.
2
Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.自身免疫性肝炎和慢性丙型肝炎病毒感染中,肝肾微粒体(LKM)抗体对细胞色素P4502D6免疫识别的差异。
Clin Exp Immunol. 1994 Jul;97(1):94-9. doi: 10.1111/j.1365-2249.1994.tb06585.x.
3
Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.采用酶联免疫吸附测定法检测成年慢性肝病患者的抗LKM-1(抗细胞色素P450 2D6)抗体。
Autoimmunity. 1999;30(2):107-14. doi: 10.3109/08916939908994768.
4
Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.丙型肝炎病毒相关的慢性肝病伴抗肝肾微粒体(LKM)自身抗体。与特发性LKM阳性疾病的临床特征比较。
J Hepatol. 1991 Jul;13(1):128-31. doi: 10.1016/0168-8278(91)90874-b.
5
Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.细胞色素P450和尿苷三磷酸葡萄糖醛酸转移酶:用于研究药物性、病毒感染性和自身免疫性肝病的模型自身抗原。
Hepatology. 1997 Oct;26(4):1054-66. doi: 10.1002/hep.510260438.
6
Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.自身免疫性肝炎和丙型肝炎病毒相关肝病中1型肝肾微粒体抗体的异质性。
Gut. 1995 Sep;37(3):406-12. doi: 10.1136/gut.37.3.406.
7
[Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].[慢性丙型肝炎病毒感染和丁型肝炎中抗微粒体自身抗体的异质性]
Ann Ital Med Int. 1995 Apr-Jun;10(2):93-7.
8
Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.慢性丙型和丁型肝炎病毒感染中肝肾微粒体自身抗体的异质性
Gastroenterology. 1995 Feb;108(2):455-62. doi: 10.1016/0016-5085(95)90074-8.
9
Anti-GOR and hepatitis C virus in autoimmune liver diseases.自身免疫性肝病中的抗GOR与丙型肝炎病毒
Lancet. 1992 Feb 1;339(8788):267-9. doi: 10.1016/0140-6736(92)91332-3.
10
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.自身免疫性肝病中中性粒细胞胞浆抗体的患病率及特征
Hepatology. 1993 Mar;17(3):411-7.

引用本文的文献

1
Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease.自身免疫性肝炎和丙型肝炎的自身抗体谱揭示了重症患者的相似之处。
World J Gastroenterol. 2017 Feb 28;23(8):1345-1352. doi: 10.3748/wjg.v23.i8.1345.
2
Autoantibodies in primary sclerosing cholangitis.原发性硬化性胆管炎中的自身抗体。
World J Gastroenterol. 2008 Jun 28;14(24):3781-91. doi: 10.3748/wjg.14.3781.
3
Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, Greece.
希腊克里特岛丙型肝炎血清学阳性受试者中1型肝肾微粒体自身抗体(LKM1)的低流行率。
BMC Gastroenterol. 2001;1:4. doi: 10.1186/1471-230x-1-4. Epub 2001 Jun 11.
4
The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis.自身免疫性肝炎中自身免疫标志物与不同临床综合征之间的关系。
Gut. 1998 May;42(5):599-602. doi: 10.1136/gut.42.5.599.